nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Rosuvastatin—atherosclerosis	0.0654	0.0939	CbGbCtD
Oxybutynin—CYP3A5—Simvastatin—atherosclerosis	0.0608	0.0873	CbGbCtD
Oxybutynin—CYP3A5—Pravastatin—atherosclerosis	0.0595	0.0854	CbGbCtD
Oxybutynin—CYP3A5—Lovastatin—atherosclerosis	0.0595	0.0854	CbGbCtD
Oxybutynin—CYP2C8—Simvastatin—atherosclerosis	0.0585	0.0839	CbGbCtD
Oxybutynin—CYP2C8—Pravastatin—atherosclerosis	0.0572	0.0821	CbGbCtD
Oxybutynin—CYP2C8—Lovastatin—atherosclerosis	0.0572	0.0821	CbGbCtD
Oxybutynin—CYP2D6—Niacin—atherosclerosis	0.0472	0.0677	CbGbCtD
Oxybutynin—CYP2D6—Simvastatin—atherosclerosis	0.0373	0.0535	CbGbCtD
Oxybutynin—CYP2D6—Pravastatin—atherosclerosis	0.0365	0.0524	CbGbCtD
Oxybutynin—CYP2D6—Lovastatin—atherosclerosis	0.0365	0.0524	CbGbCtD
Oxybutynin—CYP3A4—Rosuvastatin—atherosclerosis	0.0255	0.0366	CbGbCtD
Oxybutynin—CYP3A4—Ezetimibe—atherosclerosis	0.0255	0.0366	CbGbCtD
Oxybutynin—CYP3A4—Simvastatin—atherosclerosis	0.0237	0.034	CbGbCtD
Oxybutynin—CYP3A4—Lovastatin—atherosclerosis	0.0232	0.0333	CbGbCtD
Oxybutynin—CYP3A4—Pravastatin—atherosclerosis	0.0232	0.0333	CbGbCtD
Oxybutynin—Cough—Rosuvastatin—atherosclerosis	0.000565	0.00247	CcSEcCtD
Oxybutynin—Angiopathy—Ezetimibe—atherosclerosis	0.000561	0.00245	CcSEcCtD
Oxybutynin—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000557	0.00244	CcSEcCtD
Oxybutynin—Sinusitis—Pravastatin—atherosclerosis	0.000557	0.00244	CcSEcCtD
Oxybutynin—Arthralgia—Rosuvastatin—atherosclerosis	0.000551	0.00241	CcSEcCtD
Oxybutynin—Flushing—Simvastatin—atherosclerosis	0.000547	0.00239	CcSEcCtD
Oxybutynin—Rhinitis—Niacin—atherosclerosis	0.000543	0.00237	CcSEcCtD
Oxybutynin—Mental disorder—Ezetimibe—atherosclerosis	0.000541	0.00237	CcSEcCtD
Oxybutynin—Flatulence—Lovastatin—atherosclerosis	0.000541	0.00237	CcSEcCtD
Oxybutynin—Hypoaesthesia—Niacin—atherosclerosis	0.000538	0.00236	CcSEcCtD
Oxybutynin—Erythema—Ezetimibe—atherosclerosis	0.000538	0.00235	CcSEcCtD
Oxybutynin—Malnutrition—Ezetimibe—atherosclerosis	0.000538	0.00235	CcSEcCtD
Oxybutynin—Dysgeusia—Lovastatin—atherosclerosis	0.000537	0.00235	CcSEcCtD
Oxybutynin—Rhinitis—Pravastatin—atherosclerosis	0.000534	0.00234	CcSEcCtD
Oxybutynin—Oedema peripheral—Niacin—atherosclerosis	0.000533	0.00233	CcSEcCtD
Oxybutynin—Confusional state—Rosuvastatin—atherosclerosis	0.000533	0.00233	CcSEcCtD
Oxybutynin—Back pain—Lovastatin—atherosclerosis	0.000531	0.00232	CcSEcCtD
Oxybutynin—Hypoaesthesia—Pravastatin—atherosclerosis	0.00053	0.00232	CcSEcCtD
Oxybutynin—Flatulence—Ezetimibe—atherosclerosis	0.00053	0.00232	CcSEcCtD
Oxybutynin—Pharyngitis—Pravastatin—atherosclerosis	0.000529	0.00231	CcSEcCtD
Oxybutynin—Infection—Rosuvastatin—atherosclerosis	0.000525	0.0023	CcSEcCtD
Oxybutynin—Visual impairment—Niacin—atherosclerosis	0.000522	0.00228	CcSEcCtD
Oxybutynin—Back pain—Ezetimibe—atherosclerosis	0.00052	0.00228	CcSEcCtD
Oxybutynin—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000518	0.00227	CcSEcCtD
Oxybutynin—Vision blurred—Lovastatin—atherosclerosis	0.000517	0.00226	CcSEcCtD
Oxybutynin—Mental disorder—Simvastatin—atherosclerosis	0.000516	0.00226	CcSEcCtD
Oxybutynin—Visual impairment—Pravastatin—atherosclerosis	0.000514	0.00225	CcSEcCtD
Oxybutynin—Erythema—Simvastatin—atherosclerosis	0.000513	0.00225	CcSEcCtD
Oxybutynin—Ill-defined disorder—Lovastatin—atherosclerosis	0.000509	0.00223	CcSEcCtD
Oxybutynin—Eye disorder—Niacin—atherosclerosis	0.000506	0.00221	CcSEcCtD
Oxybutynin—Flatulence—Simvastatin—atherosclerosis	0.000506	0.00221	CcSEcCtD
Oxybutynin—Tinnitus—Niacin—atherosclerosis	0.000505	0.00221	CcSEcCtD
Oxybutynin—Dysgeusia—Simvastatin—atherosclerosis	0.000502	0.0022	CcSEcCtD
Oxybutynin—Flushing—Niacin—atherosclerosis	0.000502	0.0022	CcSEcCtD
Oxybutynin—Angioedema—Lovastatin—atherosclerosis	0.000501	0.00219	CcSEcCtD
Oxybutynin—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000499	0.00218	CcSEcCtD
Oxybutynin—Tinnitus—Pravastatin—atherosclerosis	0.000497	0.00217	CcSEcCtD
Oxybutynin—Malaise—Lovastatin—atherosclerosis	0.000495	0.00216	CcSEcCtD
Oxybutynin—Flushing—Pravastatin—atherosclerosis	0.000495	0.00216	CcSEcCtD
Oxybutynin—Cardiac disorder—Pravastatin—atherosclerosis	0.000495	0.00216	CcSEcCtD
Oxybutynin—Angioedema—Ezetimibe—atherosclerosis	0.000492	0.00215	CcSEcCtD
Oxybutynin—Angiopathy—Niacin—atherosclerosis	0.000491	0.00215	CcSEcCtD
Oxybutynin—Malaise—Ezetimibe—atherosclerosis	0.000485	0.00212	CcSEcCtD
Oxybutynin—Vision blurred—Simvastatin—atherosclerosis	0.000484	0.00212	CcSEcCtD
Oxybutynin—Arrhythmia—Niacin—atherosclerosis	0.000483	0.00212	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000481	0.00211	CcSEcCtD
Oxybutynin—Insomnia—Rosuvastatin—atherosclerosis	0.000478	0.00209	CcSEcCtD
Oxybutynin—Ill-defined disorder—Simvastatin—atherosclerosis	0.000476	0.00208	CcSEcCtD
Oxybutynin—Arrhythmia—Pravastatin—atherosclerosis	0.000476	0.00208	CcSEcCtD
Oxybutynin—Palpitations—Ezetimibe—atherosclerosis	0.000475	0.00208	CcSEcCtD
Oxybutynin—Paraesthesia—Rosuvastatin—atherosclerosis	0.000474	0.00208	CcSEcCtD
Oxybutynin—Malnutrition—Niacin—atherosclerosis	0.000471	0.00206	CcSEcCtD
Oxybutynin—Erythema—Niacin—atherosclerosis	0.000471	0.00206	CcSEcCtD
Oxybutynin—Cough—Ezetimibe—atherosclerosis	0.00047	0.00205	CcSEcCtD
Oxybutynin—Angioedema—Simvastatin—atherosclerosis	0.000469	0.00205	CcSEcCtD
Oxybutynin—Chest pain—Lovastatin—atherosclerosis	0.000467	0.00204	CcSEcCtD
Oxybutynin—Arthralgia—Lovastatin—atherosclerosis	0.000467	0.00204	CcSEcCtD
Oxybutynin—Anxiety—Lovastatin—atherosclerosis	0.000465	0.00204	CcSEcCtD
Oxybutynin—Dyspepsia—Rosuvastatin—atherosclerosis	0.000465	0.00204	CcSEcCtD
Oxybutynin—Hypertension—Ezetimibe—atherosclerosis	0.000465	0.00203	CcSEcCtD
Oxybutynin—Flatulence—Niacin—atherosclerosis	0.000464	0.00203	CcSEcCtD
Oxybutynin—Malaise—Simvastatin—atherosclerosis	0.000463	0.00203	CcSEcCtD
Oxybutynin—Tension—Niacin—atherosclerosis	0.000462	0.00202	CcSEcCtD
Oxybutynin—Discomfort—Lovastatin—atherosclerosis	0.000461	0.00202	CcSEcCtD
Oxybutynin—Arthralgia—Ezetimibe—atherosclerosis	0.000458	0.002	CcSEcCtD
Oxybutynin—Chest pain—Ezetimibe—atherosclerosis	0.000458	0.002	CcSEcCtD
Oxybutynin—Nervousness—Niacin—atherosclerosis	0.000458	0.002	CcSEcCtD
Oxybutynin—Flatulence—Pravastatin—atherosclerosis	0.000457	0.002	CcSEcCtD
Oxybutynin—Dry mouth—Lovastatin—atherosclerosis	0.000457	0.002	CcSEcCtD
Oxybutynin—Tension—Pravastatin—atherosclerosis	0.000455	0.00199	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000455	0.00199	CcSEcCtD
Oxybutynin—Dysgeusia—Pravastatin—atherosclerosis	0.000454	0.00199	CcSEcCtD
Oxybutynin—Discomfort—Ezetimibe—atherosclerosis	0.000453	0.00198	CcSEcCtD
Oxybutynin—Pain—Rosuvastatin—atherosclerosis	0.000452	0.00198	CcSEcCtD
Oxybutynin—Constipation—Rosuvastatin—atherosclerosis	0.000452	0.00198	CcSEcCtD
Oxybutynin—Confusional state—Lovastatin—atherosclerosis	0.000451	0.00198	CcSEcCtD
Oxybutynin—Nervousness—Pravastatin—atherosclerosis	0.000451	0.00197	CcSEcCtD
Oxybutynin—Dry mouth—Ezetimibe—atherosclerosis	0.000448	0.00196	CcSEcCtD
Oxybutynin—Anaphylactic shock—Lovastatin—atherosclerosis	0.000448	0.00196	CcSEcCtD
Oxybutynin—Infection—Lovastatin—atherosclerosis	0.000445	0.00195	CcSEcCtD
Oxybutynin—Vision blurred—Niacin—atherosclerosis	0.000444	0.00194	CcSEcCtD
Oxybutynin—Confusional state—Ezetimibe—atherosclerosis	0.000443	0.00194	CcSEcCtD
Oxybutynin—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000439	0.00192	CcSEcCtD
Oxybutynin—Vision blurred—Pravastatin—atherosclerosis	0.000437	0.00191	CcSEcCtD
Oxybutynin—Arthralgia—Simvastatin—atherosclerosis	0.000437	0.00191	CcSEcCtD
Oxybutynin—Chest pain—Simvastatin—atherosclerosis	0.000437	0.00191	CcSEcCtD
Oxybutynin—Infection—Ezetimibe—atherosclerosis	0.000436	0.00191	CcSEcCtD
Oxybutynin—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000435	0.00191	CcSEcCtD
Oxybutynin—Anxiety—Simvastatin—atherosclerosis	0.000435	0.00191	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000432	0.00189	CcSEcCtD
Oxybutynin—Discomfort—Simvastatin—atherosclerosis	0.000432	0.00189	CcSEcCtD
Oxybutynin—Nervous system disorder—Ezetimibe—atherosclerosis	0.000431	0.00188	CcSEcCtD
Oxybutynin—Angioedema—Niacin—atherosclerosis	0.00043	0.00188	CcSEcCtD
Oxybutynin—Ill-defined disorder—Pravastatin—atherosclerosis	0.00043	0.00188	CcSEcCtD
Oxybutynin—Anorexia—Lovastatin—atherosclerosis	0.000427	0.00187	CcSEcCtD
Oxybutynin—Skin disorder—Ezetimibe—atherosclerosis	0.000427	0.00187	CcSEcCtD
Oxybutynin—Angioedema—Pravastatin—atherosclerosis	0.000424	0.00186	CcSEcCtD
Oxybutynin—Syncope—Niacin—atherosclerosis	0.000423	0.00185	CcSEcCtD
Oxybutynin—Confusional state—Simvastatin—atherosclerosis	0.000422	0.00185	CcSEcCtD
Oxybutynin—Urticaria—Rosuvastatin—atherosclerosis	0.00042	0.00184	CcSEcCtD
Oxybutynin—Anaphylactic shock—Simvastatin—atherosclerosis	0.000419	0.00183	CcSEcCtD
Oxybutynin—Oedema—Simvastatin—atherosclerosis	0.000419	0.00183	CcSEcCtD
Oxybutynin—Malaise—Pravastatin—atherosclerosis	0.000418	0.00183	CcSEcCtD
Oxybutynin—Abdominal pain—Rosuvastatin—atherosclerosis	0.000418	0.00183	CcSEcCtD
Oxybutynin—Palpitations—Niacin—atherosclerosis	0.000416	0.00182	CcSEcCtD
Oxybutynin—Infection—Simvastatin—atherosclerosis	0.000416	0.00182	CcSEcCtD
Oxybutynin—Loss of consciousness—Niacin—atherosclerosis	0.000414	0.00181	CcSEcCtD
Oxybutynin—Cough—Niacin—atherosclerosis	0.000411	0.0018	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000408	0.00179	CcSEcCtD
Oxybutynin—Insomnia—Lovastatin—atherosclerosis	0.000405	0.00177	CcSEcCtD
Oxybutynin—Cough—Pravastatin—atherosclerosis	0.000405	0.00177	CcSEcCtD
Oxybutynin—Paraesthesia—Lovastatin—atherosclerosis	0.000402	0.00176	CcSEcCtD
Oxybutynin—Arthralgia—Niacin—atherosclerosis	0.000401	0.00176	CcSEcCtD
Oxybutynin—Hypertension—Pravastatin—atherosclerosis	0.0004	0.00175	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0004	0.00175	CcSEcCtD
Oxybutynin—Anorexia—Simvastatin—atherosclerosis	0.000399	0.00175	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000398	0.00174	CcSEcCtD
Oxybutynin—Insomnia—Ezetimibe—atherosclerosis	0.000397	0.00174	CcSEcCtD
Oxybutynin—Arthralgia—Pravastatin—atherosclerosis	0.000395	0.00173	CcSEcCtD
Oxybutynin—Chest pain—Pravastatin—atherosclerosis	0.000395	0.00173	CcSEcCtD
Oxybutynin—Paraesthesia—Ezetimibe—atherosclerosis	0.000394	0.00173	CcSEcCtD
Oxybutynin—Dyspepsia—Lovastatin—atherosclerosis	0.000394	0.00172	CcSEcCtD
Oxybutynin—Anxiety—Pravastatin—atherosclerosis	0.000394	0.00172	CcSEcCtD
Oxybutynin—Dry mouth—Niacin—atherosclerosis	0.000392	0.00172	CcSEcCtD
Oxybutynin—Discomfort—Pravastatin—atherosclerosis	0.00039	0.00171	CcSEcCtD
Oxybutynin—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000389	0.0017	CcSEcCtD
Oxybutynin—Decreased appetite—Lovastatin—atherosclerosis	0.000389	0.0017	CcSEcCtD
Oxybutynin—Dyspepsia—Ezetimibe—atherosclerosis	0.000387	0.00169	CcSEcCtD
Oxybutynin—Fatigue—Lovastatin—atherosclerosis	0.000386	0.00169	CcSEcCtD
Oxybutynin—Anaphylactic shock—Niacin—atherosclerosis	0.000385	0.00168	CcSEcCtD
Oxybutynin—Oedema—Niacin—atherosclerosis	0.000385	0.00168	CcSEcCtD
Oxybutynin—Pain—Lovastatin—atherosclerosis	0.000383	0.00168	CcSEcCtD
Oxybutynin—Constipation—Lovastatin—atherosclerosis	0.000383	0.00168	CcSEcCtD
Oxybutynin—Confusional state—Pravastatin—atherosclerosis	0.000382	0.00167	CcSEcCtD
Oxybutynin—Decreased appetite—Ezetimibe—atherosclerosis	0.000382	0.00167	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000382	0.00167	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000379	0.00166	CcSEcCtD
Oxybutynin—Asthenia—Rosuvastatin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Oxybutynin—Insomnia—Simvastatin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Oxybutynin—Anaphylactic shock—Pravastatin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Oxybutynin—Oedema—Pravastatin—atherosclerosis	0.000379	0.00166	CcSEcCtD
Oxybutynin—Fatigue—Ezetimibe—atherosclerosis	0.000379	0.00166	CcSEcCtD
Oxybutynin—Shock—Niacin—atherosclerosis	0.000378	0.00166	CcSEcCtD
Oxybutynin—Infection—Pravastatin—atherosclerosis	0.000376	0.00165	CcSEcCtD
Oxybutynin—Paraesthesia—Simvastatin—atherosclerosis	0.000376	0.00165	CcSEcCtD
Oxybutynin—Pain—Ezetimibe—atherosclerosis	0.000376	0.00164	CcSEcCtD
Oxybutynin—Constipation—Ezetimibe—atherosclerosis	0.000376	0.00164	CcSEcCtD
Oxybutynin—Tachycardia—Niacin—atherosclerosis	0.000375	0.00164	CcSEcCtD
Oxybutynin—Pruritus—Rosuvastatin—atherosclerosis	0.000374	0.00164	CcSEcCtD
Oxybutynin—Skin disorder—Niacin—atherosclerosis	0.000373	0.00163	CcSEcCtD
Oxybutynin—Feeling abnormal—Lovastatin—atherosclerosis	0.000369	0.00161	CcSEcCtD
Oxybutynin—Dyspepsia—Simvastatin—atherosclerosis	0.000369	0.00161	CcSEcCtD
Oxybutynin—Anorexia—Niacin—atherosclerosis	0.000367	0.0016	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000366	0.0016	CcSEcCtD
Oxybutynin—Decreased appetite—Simvastatin—atherosclerosis	0.000364	0.00159	CcSEcCtD
Oxybutynin—Feeling abnormal—Ezetimibe—atherosclerosis	0.000362	0.00158	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000362	0.00158	CcSEcCtD
Oxybutynin—Diarrhoea—Rosuvastatin—atherosclerosis	0.000361	0.00158	CcSEcCtD
Oxybutynin—Fatigue—Simvastatin—atherosclerosis	0.000361	0.00158	CcSEcCtD
Oxybutynin—Anorexia—Pravastatin—atherosclerosis	0.000361	0.00158	CcSEcCtD
Oxybutynin—Hypotension—Niacin—atherosclerosis	0.000359	0.00157	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000359	0.00157	CcSEcCtD
Oxybutynin—Pain—Simvastatin—atherosclerosis	0.000358	0.00157	CcSEcCtD
Oxybutynin—Constipation—Simvastatin—atherosclerosis	0.000358	0.00157	CcSEcCtD
Oxybutynin—Urticaria—Lovastatin—atherosclerosis	0.000356	0.00156	CcSEcCtD
Oxybutynin—Abdominal pain—Lovastatin—atherosclerosis	0.000354	0.00155	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00035	0.00153	CcSEcCtD
Oxybutynin—Dizziness—Rosuvastatin—atherosclerosis	0.000349	0.00153	CcSEcCtD
Oxybutynin—Urticaria—Ezetimibe—atherosclerosis	0.000349	0.00153	CcSEcCtD
Oxybutynin—Insomnia—Niacin—atherosclerosis	0.000348	0.00152	CcSEcCtD
Oxybutynin—Abdominal pain—Ezetimibe—atherosclerosis	0.000347	0.00152	CcSEcCtD
Oxybutynin—Paraesthesia—Niacin—atherosclerosis	0.000345	0.00151	CcSEcCtD
Oxybutynin—Feeling abnormal—Simvastatin—atherosclerosis	0.000345	0.00151	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000345	0.00151	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000342	0.0015	CcSEcCtD
Oxybutynin—Insomnia—Pravastatin—atherosclerosis	0.000342	0.0015	CcSEcCtD
Oxybutynin—Somnolence—Niacin—atherosclerosis	0.000342	0.0015	CcSEcCtD
Oxybutynin—Paraesthesia—Pravastatin—atherosclerosis	0.00034	0.00149	CcSEcCtD
Oxybutynin—Dyspepsia—Niacin—atherosclerosis	0.000338	0.00148	CcSEcCtD
Oxybutynin—Decreased appetite—Niacin—atherosclerosis	0.000334	0.00146	CcSEcCtD
Oxybutynin—Dyspepsia—Pravastatin—atherosclerosis	0.000333	0.00146	CcSEcCtD
Oxybutynin—Rash—Rosuvastatin—atherosclerosis	0.000333	0.00146	CcSEcCtD
Oxybutynin—Dermatitis—Rosuvastatin—atherosclerosis	0.000333	0.00146	CcSEcCtD
Oxybutynin—Urticaria—Simvastatin—atherosclerosis	0.000333	0.00146	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Niacin—atherosclerosis	0.000332	0.00145	CcSEcCtD
Oxybutynin—Abdominal pain—Simvastatin—atherosclerosis	0.000331	0.00145	CcSEcCtD
Oxybutynin—Headache—Rosuvastatin—atherosclerosis	0.000331	0.00145	CcSEcCtD
Oxybutynin—Hypersensitivity—Lovastatin—atherosclerosis	0.00033	0.00144	CcSEcCtD
Oxybutynin—Decreased appetite—Pravastatin—atherosclerosis	0.000329	0.00144	CcSEcCtD
Oxybutynin—Pain—Niacin—atherosclerosis	0.000329	0.00144	CcSEcCtD
Oxybutynin—Fatigue—Pravastatin—atherosclerosis	0.000326	0.00143	CcSEcCtD
Oxybutynin—Pain—Pravastatin—atherosclerosis	0.000324	0.00142	CcSEcCtD
Oxybutynin—Constipation—Pravastatin—atherosclerosis	0.000324	0.00142	CcSEcCtD
Oxybutynin—Hypersensitivity—Ezetimibe—atherosclerosis	0.000324	0.00142	CcSEcCtD
Oxybutynin—Asthenia—Lovastatin—atherosclerosis	0.000321	0.00141	CcSEcCtD
Oxybutynin—Pruritus—Lovastatin—atherosclerosis	0.000317	0.00139	CcSEcCtD
Oxybutynin—Asthenia—Ezetimibe—atherosclerosis	0.000315	0.00138	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Niacin—atherosclerosis	0.000314	0.00138	CcSEcCtD
Oxybutynin—Nausea—Rosuvastatin—atherosclerosis	0.000314	0.00137	CcSEcCtD
Oxybutynin—Feeling abnormal—Pravastatin—atherosclerosis	0.000312	0.00137	CcSEcCtD
Oxybutynin—Pruritus—Ezetimibe—atherosclerosis	0.000311	0.00136	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00031	0.00135	CcSEcCtD
Oxybutynin—Hypersensitivity—Simvastatin—atherosclerosis	0.000309	0.00135	CcSEcCtD
Oxybutynin—Diarrhoea—Lovastatin—atherosclerosis	0.000306	0.00134	CcSEcCtD
Oxybutynin—Urticaria—Niacin—atherosclerosis	0.000305	0.00134	CcSEcCtD
Oxybutynin—Abdominal pain—Niacin—atherosclerosis	0.000304	0.00133	CcSEcCtD
Oxybutynin—Urticaria—Pravastatin—atherosclerosis	0.000301	0.00132	CcSEcCtD
Oxybutynin—Asthenia—Simvastatin—atherosclerosis	0.0003	0.00131	CcSEcCtD
Oxybutynin—Diarrhoea—Ezetimibe—atherosclerosis	0.0003	0.00131	CcSEcCtD
Oxybutynin—Abdominal pain—Pravastatin—atherosclerosis	0.000299	0.00131	CcSEcCtD
Oxybutynin—Pruritus—Simvastatin—atherosclerosis	0.000296	0.0013	CcSEcCtD
Oxybutynin—Dizziness—Lovastatin—atherosclerosis	0.000296	0.0013	CcSEcCtD
Oxybutynin—Dizziness—Ezetimibe—atherosclerosis	0.00029	0.00127	CcSEcCtD
Oxybutynin—Diarrhoea—Simvastatin—atherosclerosis	0.000287	0.00125	CcSEcCtD
Oxybutynin—Vomiting—Lovastatin—atherosclerosis	0.000285	0.00125	CcSEcCtD
Oxybutynin—Hypersensitivity—Niacin—atherosclerosis	0.000283	0.00124	CcSEcCtD
Oxybutynin—Rash—Lovastatin—atherosclerosis	0.000282	0.00124	CcSEcCtD
Oxybutynin—Dermatitis—Lovastatin—atherosclerosis	0.000282	0.00123	CcSEcCtD
Oxybutynin—Headache—Lovastatin—atherosclerosis	0.00028	0.00123	CcSEcCtD
Oxybutynin—Vomiting—Ezetimibe—atherosclerosis	0.000279	0.00122	CcSEcCtD
Oxybutynin—Hypersensitivity—Pravastatin—atherosclerosis	0.000279	0.00122	CcSEcCtD
Oxybutynin—Dizziness—Simvastatin—atherosclerosis	0.000277	0.00121	CcSEcCtD
Oxybutynin—Rash—Ezetimibe—atherosclerosis	0.000277	0.00121	CcSEcCtD
Oxybutynin—Dermatitis—Ezetimibe—atherosclerosis	0.000277	0.00121	CcSEcCtD
Oxybutynin—Asthenia—Niacin—atherosclerosis	0.000276	0.00121	CcSEcCtD
Oxybutynin—Headache—Ezetimibe—atherosclerosis	0.000275	0.0012	CcSEcCtD
Oxybutynin—Pruritus—Niacin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Oxybutynin—Asthenia—Pravastatin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Oxybutynin—Pruritus—Pravastatin—atherosclerosis	0.000268	0.00117	CcSEcCtD
Oxybutynin—Vomiting—Simvastatin—atherosclerosis	0.000266	0.00117	CcSEcCtD
Oxybutynin—Nausea—Lovastatin—atherosclerosis	0.000266	0.00116	CcSEcCtD
Oxybutynin—Rash—Simvastatin—atherosclerosis	0.000264	0.00116	CcSEcCtD
Oxybutynin—Dermatitis—Simvastatin—atherosclerosis	0.000264	0.00115	CcSEcCtD
Oxybutynin—Diarrhoea—Niacin—atherosclerosis	0.000263	0.00115	CcSEcCtD
Oxybutynin—Headache—Simvastatin—atherosclerosis	0.000262	0.00115	CcSEcCtD
Oxybutynin—Nausea—Ezetimibe—atherosclerosis	0.000261	0.00114	CcSEcCtD
Oxybutynin—Diarrhoea—Pravastatin—atherosclerosis	0.000259	0.00113	CcSEcCtD
Oxybutynin—Dizziness—Niacin—atherosclerosis	0.000254	0.00111	CcSEcCtD
Oxybutynin—Dizziness—Pravastatin—atherosclerosis	0.00025	0.0011	CcSEcCtD
Oxybutynin—Nausea—Simvastatin—atherosclerosis	0.000249	0.00109	CcSEcCtD
Oxybutynin—Vomiting—Niacin—atherosclerosis	0.000244	0.00107	CcSEcCtD
Oxybutynin—Rash—Niacin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Oxybutynin—Dermatitis—Niacin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Oxybutynin—Headache—Niacin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Oxybutynin—Vomiting—Pravastatin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Oxybutynin—Rash—Pravastatin—atherosclerosis	0.000239	0.00104	CcSEcCtD
Oxybutynin—Dermatitis—Pravastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Oxybutynin—Headache—Pravastatin—atherosclerosis	0.000237	0.00104	CcSEcCtD
Oxybutynin—Nausea—Niacin—atherosclerosis	0.000228	0.001	CcSEcCtD
Oxybutynin—Nausea—Pravastatin—atherosclerosis	0.000225	0.000984	CcSEcCtD
Oxybutynin—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	1.39e-05	0.000185	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.38e-05	0.000185	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	1.38e-05	0.000185	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	1.37e-05	0.000183	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ABCA1—atherosclerosis	1.37e-05	0.000183	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.36e-05	0.000181	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP3—atherosclerosis	1.34e-05	0.000179	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP3—atherosclerosis	1.34e-05	0.000178	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.33e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF2—atherosclerosis	1.33e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF2—atherosclerosis	1.33e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	1.33e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—MTHFR—atherosclerosis	1.33e-05	0.000177	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP3—atherosclerosis	1.32e-05	0.000177	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF2—atherosclerosis	1.32e-05	0.000176	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.31e-05	0.000176	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARA—atherosclerosis	1.3e-05	0.000174	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOB—atherosclerosis	1.3e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOB—atherosclerosis	1.3e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOB—atherosclerosis	1.29e-05	0.000172	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.28e-05	0.000172	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	1.28e-05	0.000171	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOB—atherosclerosis	1.28e-05	0.000171	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EDN1—atherosclerosis	1.27e-05	0.00017	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	1.27e-05	0.00017	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EDN1—atherosclerosis	1.27e-05	0.00017	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	1.27e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCL5—atherosclerosis	1.26e-05	0.000169	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.26e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AGT—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCL5—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EDN1—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—INS—atherosclerosis	1.26e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCL5—atherosclerosis	1.25e-05	0.000167	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.25e-05	0.000166	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOA2—atherosclerosis	1.25e-05	0.000166	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.25e-05	0.000166	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.25e-05	0.000166	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—LPL—atherosclerosis	1.24e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCL2—atherosclerosis	1.24e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—LPL—atherosclerosis	1.24e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—APOE—atherosclerosis	1.24e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—LPL—atherosclerosis	1.23e-05	0.000165	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.23e-05	0.000164	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CAV1—atherosclerosis	1.22e-05	0.000164	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—APOA1—atherosclerosis	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—LPL—atherosclerosis	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IGF1—atherosclerosis	1.22e-05	0.000163	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GPX1—atherosclerosis	1.21e-05	0.000162	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	1.2e-05	0.000161	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	1.2e-05	0.00016	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LPA—atherosclerosis	1.19e-05	0.000159	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	1.19e-05	0.000159	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CD36—atherosclerosis	1.18e-05	0.000157	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HMOX1—atherosclerosis	1.17e-05	0.000157	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SPP1—atherosclerosis	1.17e-05	0.000156	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SPP1—atherosclerosis	1.17e-05	0.000156	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.17e-05	0.000156	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	1.16e-05	0.000155	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SPP1—atherosclerosis	1.16e-05	0.000154	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	1.16e-05	0.000154	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—BGN—atherosclerosis	1.15e-05	0.000154	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	1.15e-05	0.000154	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOA5—atherosclerosis	1.14e-05	0.000152	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOB—atherosclerosis	1.12e-05	0.00015	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.12e-05	0.00015	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—MTHFR—atherosclerosis	1.12e-05	0.000149	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CG—atherosclerosis	1.12e-05	0.000149	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOS3—atherosclerosis	1.1e-05	0.000147	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.1e-05	0.000147	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARA—atherosclerosis	1.09e-05	0.000146	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTM1—atherosclerosis	1.09e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	1.08e-05	0.000145	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	1.08e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—atherosclerosis	1.08e-05	0.000144	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—LPL—atherosclerosis	1.07e-05	0.000143	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	1.07e-05	0.000143	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AGT—atherosclerosis	1.06e-05	0.000142	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.06e-05	0.000142	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGT—atherosclerosis	1.06e-05	0.000141	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—INS—atherosclerosis	1.06e-05	0.000141	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGT—atherosclerosis	1.05e-05	0.000141	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GPX1—atherosclerosis	1.05e-05	0.00014	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGT—atherosclerosis	1.04e-05	0.00014	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOE—atherosclerosis	1.04e-05	0.000139	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOE—atherosclerosis	1.04e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—LEP—atherosclerosis	1.04e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—LEP—atherosclerosis	1.03e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOE—atherosclerosis	1.03e-05	0.000138	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CAV1—atherosclerosis	1.03e-05	0.000138	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—APOA1—atherosclerosis	1.03e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CAV1—atherosclerosis	1.03e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APOA1—atherosclerosis	1.02e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CAV1—atherosclerosis	1.02e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOE—atherosclerosis	1.02e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—LEP—atherosclerosis	1.02e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APOA1—atherosclerosis	1.02e-05	0.000136	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CD36—atherosclerosis	1.02e-05	0.000136	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CAV1—atherosclerosis	1.01e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APOA1—atherosclerosis	1.01e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ESR1—atherosclerosis	9.9e-06	0.000132	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ESR1—atherosclerosis	9.86e-06	0.000132	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	9.78e-06	0.000131	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—F2—atherosclerosis	9.78e-06	0.000131	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ESR1—atherosclerosis	9.77e-06	0.000131	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—F2—atherosclerosis	9.74e-06	0.00013	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALB—atherosclerosis	9.68e-06	0.000129	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—MTHFR—atherosclerosis	9.67e-06	0.000129	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—F2—atherosclerosis	9.65e-06	0.000129	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMOX1—atherosclerosis	9.64e-06	0.000129	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.5e-06	0.000127	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARA—atherosclerosis	9.48e-06	0.000127	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	9.45e-06	0.000126	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LIPC—atherosclerosis	9.44e-06	0.000126	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOC3—atherosclerosis	9.39e-06	0.000125	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CG—atherosclerosis	9.38e-06	0.000125	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	9.35e-06	0.000125	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LDLR—atherosclerosis	9.33e-06	0.000125	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	9.32e-06	0.000125	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—IL6—atherosclerosis	9.3e-06	0.000124	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NOS3—atherosclerosis	9.26e-06	0.000124	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	9.23e-06	0.000123	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOB—atherosclerosis	9.23e-06	0.000123	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AGT—atherosclerosis	9.19e-06	0.000123	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CETP—atherosclerosis	9.11e-06	0.000122	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—atherosclerosis	9.05e-06	0.000121	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOE—atherosclerosis	9e-06	0.00012	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTM1—atherosclerosis	8.98e-06	0.00012	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	8.96e-06	0.00012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	8.93e-06	0.000119	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CAV1—atherosclerosis	8.92e-06	0.000119	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—APOA1—atherosclerosis	8.9e-06	0.000119	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—INS—atherosclerosis	8.88e-06	0.000119	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—INS—atherosclerosis	8.86e-06	0.000118	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—atherosclerosis	8.85e-06	0.000118	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	8.84e-06	0.000118	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—INS—atherosclerosis	8.83e-06	0.000118	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—LPL—atherosclerosis	8.81e-06	0.000118	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	8.75e-06	0.000117	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—INS—atherosclerosis	8.74e-06	0.000117	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SCARB1—atherosclerosis	8.73e-06	0.000117	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCL2—atherosclerosis	8.71e-06	0.000116	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCL2—atherosclerosis	8.68e-06	0.000116	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	8.61e-06	0.000115	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCL2—atherosclerosis	8.6e-06	0.000115	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GPX1—atherosclerosis	8.6e-06	0.000115	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	8.58e-06	0.000115	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IGF1—atherosclerosis	8.57e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IGF1—atherosclerosis	8.54e-06	0.000114	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—atherosclerosis	8.47e-06	0.000113	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IGF1—atherosclerosis	8.46e-06	0.000113	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CD36—atherosclerosis	8.38e-06	0.000112	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.24e-06	0.00011	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALB—atherosclerosis	8.14e-06	0.000109	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	8.13e-06	0.000109	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—atherosclerosis	8.12e-06	0.000109	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	8.11e-06	0.000108	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	8.03e-06	0.000107	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	7.95e-06	0.000106	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—MTHFR—atherosclerosis	7.94e-06	0.000106	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—atherosclerosis	7.87e-06	0.000105	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—atherosclerosis	7.84e-06	0.000105	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARA—atherosclerosis	7.79e-06	0.000104	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NOS3—atherosclerosis	7.78e-06	0.000104	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOS3—atherosclerosis	7.77e-06	0.000104	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOS3—atherosclerosis	7.74e-06	0.000103	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—INS—atherosclerosis	7.69e-06	0.000103	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOS3—atherosclerosis	7.67e-06	0.000102	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AGT—atherosclerosis	7.54e-06	0.000101	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	7.52e-06	0.0001	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOE—atherosclerosis	7.39e-06	9.87e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.34e-06	9.81e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAV1—atherosclerosis	7.32e-06	9.78e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—APOA1—atherosclerosis	7.3e-06	9.76e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	7.29e-06	9.74e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—atherosclerosis	7.12e-06	9.51e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALB—atherosclerosis	7.05e-06	9.42e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	6.89e-06	9.2e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	6.87e-06	9.17e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	6.8e-06	9.08e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NOS3—atherosclerosis	6.74e-06	9.01e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—atherosclerosis	6.67e-06	8.91e-05	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	6.65e-06	8.89e-05	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	6.63e-06	8.86e-05	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	6.57e-06	8.78e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL6—atherosclerosis	6.55e-06	8.75e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL6—atherosclerosis	6.53e-06	8.72e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL6—atherosclerosis	6.47e-06	8.64e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—atherosclerosis	6.44e-06	8.6e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—INS—atherosclerosis	6.31e-06	8.43e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.3e-06	8.42e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—atherosclerosis	6.23e-06	8.32e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—atherosclerosis	6.21e-06	8.3e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—atherosclerosis	6.17e-06	8.24e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	6.16e-06	8.24e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—atherosclerosis	6.15e-06	8.22e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	6.14e-06	8.21e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	6.08e-06	8.13e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	6.06e-06	8.1e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	6.04e-06	8.07e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	6.04e-06	8.07e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOB—atherosclerosis	6.04e-06	8.06e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	6.02e-06	8.05e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	5.98e-06	7.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	5.96e-06	7.97e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.87e-06	7.84e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALB—atherosclerosis	5.79e-06	7.73e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—LPL—atherosclerosis	5.76e-06	7.7e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPX1—atherosclerosis	5.62e-06	7.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	5.59e-06	7.47e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	5.58e-06	7.45e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—atherosclerosis	5.54e-06	7.4e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NOS3—atherosclerosis	5.54e-06	7.4e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	5.52e-06	7.38e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—atherosclerosis	5.52e-06	7.38e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL6—atherosclerosis	5.5e-06	7.34e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CD36—atherosclerosis	5.48e-06	7.32e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—atherosclerosis	5.47e-06	7.31e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	5.29e-06	7.07e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	5.28e-06	7.05e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	5.22e-06	6.98e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.19e-06	6.93e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	5.13e-06	6.86e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	5.12e-06	6.84e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARA—atherosclerosis	5.09e-06	6.8e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—atherosclerosis	5.07e-06	6.77e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	5.07e-06	6.77e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.06e-06	6.76e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AGT—atherosclerosis	4.93e-06	6.59e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOE—atherosclerosis	4.83e-06	6.45e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAV1—atherosclerosis	4.79e-06	6.39e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—APOA1—atherosclerosis	4.78e-06	6.38e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.36e-06	5.82e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—atherosclerosis	4.26e-06	5.69e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—atherosclerosis	4.21e-06	5.62e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—INS—atherosclerosis	4.13e-06	5.51e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL6—atherosclerosis	3.87e-06	5.17e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL6—atherosclerosis	3.86e-06	5.15e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL6—atherosclerosis	3.82e-06	5.1e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALB—atherosclerosis	3.78e-06	5.05e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NOS3—atherosclerosis	3.62e-06	4.84e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—atherosclerosis	3.58e-06	4.78e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—atherosclerosis	3.57e-06	4.77e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—atherosclerosis	3.56e-06	4.75e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—atherosclerosis	3.52e-06	4.71e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.31e-06	4.42e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—atherosclerosis	3.1e-06	4.14e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—atherosclerosis	2.54e-06	3.4e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—atherosclerosis	1.66e-06	2.22e-05	CbGpPWpGaD
